Akorn, Inc. (NASDAQ:AKRX) Given Average Recommendation of “Hold” by Analysts
Akorn, Inc. (NASDAQ:AKRX) has earned a consensus rating of “Hold” from the eighteen ratings firms that are currently covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell recommendation, eleven have issued a hold recommendation and three have issued a buy recommendation on the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $30.55.
A number of brokerages have recently issued reports on AKRX. Royal Bank Of Canada set a $34.00 price target on Akorn and gave the company a “hold” rating in a report on Tuesday, June 27th. Craig Hallum downgraded Akorn from a “buy” rating to a “hold” rating in a report on Tuesday, April 25th. Zacks Investment Research upgraded Akorn from a “sell” rating to a “hold” rating in a report on Monday, May 8th. Gabelli reiterated a “hold” rating on shares of Akorn in a report on Tuesday, April 25th. Finally, William Blair downgraded Akorn from an “outperform” rating to a “market perform” rating in a report on Tuesday, April 25th.
Shares of Akorn (NASDAQ AKRX) traded up 0.16% on Monday, reaching $33.70. The company’s stock had a trading volume of 1,401,266 shares. The company has a market capitalization of $4.20 billion, a price-to-earnings ratio of 23.00 and a beta of 1.36. The company’s 50-day moving average is $33.32 and its 200 day moving average is $26.53. Akorn has a 12-month low of $17.61 and a 12-month high of $35.40.
A number of hedge funds have recently modified their holdings of the company. NEXT Financial Group Inc boosted its stake in shares of Akorn by 990.9% in the first quarter. NEXT Financial Group Inc now owns 3,000 shares of the company’s stock worth $100,000 after buying an additional 2,725 shares in the last quarter. Meadow Creek Investment Management LLC boosted its stake in shares of Akorn by 8.3% in the first quarter. Meadow Creek Investment Management LLC now owns 4,368 shares of the company’s stock worth $105,000 after buying an additional 336 shares in the last quarter. Glen Harbor Capital Management LLC boosted its stake in shares of Akorn by 8.3% in the first quarter. Glen Harbor Capital Management LLC now owns 5,304 shares of the company’s stock worth $128,000 after buying an additional 408 shares in the last quarter. Private Advisor Group LLC purchased a new stake in shares of Akorn during the first quarter worth approximately $164,000. Finally, LS Investment Advisors LLC boosted its stake in shares of Akorn by 21.8% in the first quarter. LS Investment Advisors LLC now owns 7,850 shares of the company’s stock worth $189,000 after buying an additional 1,407 shares in the last quarter. 76.09% of the stock is owned by institutional investors.
Akorn Company Profile
Akorn Inc (Akorn), together with its subsidiaries, is a specialty generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as private-label over-the-counter (OTC) consumer health products and animal health pharmaceuticals. The Company operates through two segments: Prescription Pharmaceuticals and the Consumer Health.
Receive News & Ratings for Akorn Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akorn Inc. and related companies with MarketBeat.com's FREE daily email newsletter.